IPO YEAR:
|
Sector:
Health Care
|
Industry:
Biotechnology: In Vitro & In Vivo Diagnostic Substances
|
ADRTSO:
|
MarketCap:
1202102909.00
|
Beta:
1.212528687347942
|
52 Week High:
6.27
|
52 Week Low:
3.26
|
52 Week Change:
0.3137755102040818
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
681341306
|
Dividend Rate:
0
|
Dividend Yield:
1.33%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
26 Oct 2022
|
Float:
0
|
return on Equity:
-11.00%
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
$120.130M
|
ttmEPS:
0.1177
|
Revenue:
$284.916M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
58.10%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
15.70%
|
Return on Assets:
-3.50%
|
Return on Capital:
|
Profit Margin:
-2.60%
|
Price to Sales:
0.23
|
Price To Book:
0.98
|
Short Ratio:
4.15
|
PE Ratio:
46.21301118018149
|
Employees:
5269
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
